Status:

UNKNOWN

Dual PETOvac - Dual Time PET/CT in the Preoperative Assessment of Ovarian Cancer

Lead Sponsor:

Odense University Hospital

Conditions:

Ovarian Cancer

Eligibility:

FEMALE

18+ years

Brief Summary

The investigators want to compare the use of MRI with PET/CT preformed after 1 hour and 3 hours in preoperative assessment of resectability. The investigators' hypothesis is that dual time PET/CT per...

Detailed Description

The use of PET/CT in ovarian cancer has not been well-established. The diagnosis usually includes physical examination (incl. pelvic examination), blood test incl. CA-125 and transvaginal ultrasound....

Eligibility Criteria

Inclusion

  • Suspicion of ovarian cancer
  • Referred to Department of Gynecology, OUH

Exclusion

  • Unable to corporate to MR
  • Diabetes Mellitus
  • Prescan glucose level \> 10 mmol/l (PET)
  • non-ovarian cancer (incl. benign)

Key Trial Info

Start Date :

August 1 2013

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 1 2017

Estimated Enrollment :

180 Patients enrolled

Trial Details

Trial ID

NCT01889615

Start Date

August 1 2013

End Date

January 1 2017

Last Update

October 6 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Nuclear Medicine

Odense C, Fünen, Denmark, 5000

Dual PETOvac - Dual Time PET/CT in the Preoperative Assessment of Ovarian Cancer | DecenTrialz